← Back to Search

Behavioural Intervention

Virtual Reality Driving Simulator for Dementia

N/A
Recruiting
Led By Zahra Moussavi
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Residents with significant mobility issues (wheelchair users) will be excluded
Residents with significant visual impairment will be excluded.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every week for a maximum of 52 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to use a virtual reality driving simulator to help improve the mood and quality of life of Alzheimer's/dementia patients at Riverview Health Center. The simulator has different levels of difficulty and is

Who is the study for?
This trial is for institutionalized dementia patients, particularly those who cannot perform standard assessments. It aims to improve their mood and quality of life by using a virtual reality driving simulator (VRDS). The study seeks individuals with varying levels of cognitive impairment but will likely use the easiest level of the VRDS.
What is being tested?
The trial is testing whether a VR driving simulator can enhance mood and implicit memory in dementia patients. Nurses at Riverview Health Center will observe changes in patient behavior, while game scores will indicate potential improvements in memory based on driving performance.
What are the potential side effects?
While not explicitly mentioned, possible side effects may include dizziness or motion sickness due to VR usage, discomfort from wearing the headset, or frustration if patients find it difficult to interact with the technology.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not use a wheelchair for mobility.
Select...
I do not have significant visual impairment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every week for a maximum of 52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and every week for a maximum of 52 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Nurses overall observations of the study participants on a scale of -1, 0 and 1 for worse, no change and improved, respectively.
Secondary study objectives
The Game's score through the period of the study on a value between 0 to 100 for the minimum and maximum score in the game.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VRDS usersExperimental Treatment1 Intervention
Individuals who would use the VRDS

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,543 Total Patients Enrolled
8 Trials studying Dementia
1,389 Patients Enrolled for Dementia
Zahra MoussaviPrincipal InvestigatorUniversity of Manitoba
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top